(Q34627172)

3 August 2017

1 reference

title

Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life (English)

1 reference

3 August 2017

main subject

temporal lobe epilepsy

1 reference

1 reference

Christian G Bien

1

1 reference

3 August 2017

Christian E Elger

series ordinal

2

1 reference

3 August 2017

publication date

9 May 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

10

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

529-538

1 reference

"Limbic encephalitis" and its association with carcinoma

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Neuronal antinuclear antibody in sensory neuronopathy from lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Clinical analysis of anti-Ma2-associated encephalitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Are the "newly discovered" paraneoplastic anticollapsin response-mediator protein 5 antibodies simply anti-CV2 antibodies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Paraneoplastic limbic encephalitis (PLE) and chorea associated with CRMP-5 neuronal antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

BR serine/threonine kinase 2: a new autoantigen in paraneoplastic limbic encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Voltage‐gated potassium channel antibodies in limbic encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Paraneoplastic limbic encephalitis associated with potassium channel antibodies: value of anti-glial nuclear antibodies in identifying the tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

[VGKC antibodies associated with limbic encephalitis]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Limbic encephalitis: extension of the diagnostic armamentarium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Non-herpetic acute limbic encephalitis: cerebrospinal fluid cytokines and magnetic resonance imaging findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Non-herpetic acute limbic encephalitis: a new subgroup of limbic encephalitis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Acute limbic encephalitis: a new entity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Successful immune treatment for non-paraneoplastic limbic encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Imaging of the epilepsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Serial MRI of limbic encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Magnetic resonance imaging evidence of hippocampal sclerosis in progression: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

The hippocampus in status epilepticus: demonstration of signal intensity and morphologic changes with sequential fast spin-echo MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Development of hippocampal atrophy: a serial magnetic resonance imaging study in a patient who developed epilepsy after generalized status epilepticus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

An MRI and neuropathological study of a case of fatal status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Potassium channel antibodies in two patients with reversible limbic encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Pathology of pure hippocampal sclerosis in a patient with dementia and Hodgkin's disease: the Ophelia syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Surgical treatment of limbic epilepsy associated with extrahippocampal lesions: the problem of dual pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Temporal lobe epilepsy: analysis of patients with dual pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

[18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Human herpesvirus 6 limbic encephalitis after stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Amnesic syndrome with bilateral mesial temporal lobe involvement in Hashimoto's encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Steroid-responsive encephalopathy associated with autoimmune thyroiditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Nervous system lupus mimics limbic encephalitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Neurosyphilis and paraneoplastic limbic encephalitis: important differential diagnoses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Management of paraneoplastic neurological syndromes: report of an EFNS Task Force

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

A new cause of limbic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

T-cells in human encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

Prospective study of seizures in the elderly in the Marshfield Epidemiologic Study Area (MESA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.011

10.1016/J.YEBEH.2007.03.011

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference